1 – 10 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia : focus on the very early period and Omicron era
- Contribution to journal › Article
-
Mark
Genetic variation at PPM1H predicts mobilization efficiency in stem cell donors
- Contribution to journal › Letter
-
Mark
Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder
(2025) In Blood Advances
- Contribution to journal › Article
-
Mark
Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma
- Contribution to journal › Article
- 2024
-
Mark
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV : a report from the REPRIEVE trial
- Contribution to journal › Article
-
Mark
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma : the Nordic Lymphoma Group MCL7 VALERIA trial
- Contribution to journal › Article
-
Mark
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
- Contribution to journal › Article
-
Mark
A temporal developmental map separates human NK cells from noncytotoxic ILCs through clonal and single-cell analysis
- Contribution to journal › Article
-
Mark
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
- Contribution to journal › Article
-
Mark
CD4+CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy
- Contribution to journal › Article
